Related Experiment Videos

BRK/Sik expression in the gastrointestinal tract and in colon tumors

X Llor1, M S Serfas, W Bie

  • 1Department of Molecular Genetics, University of Illinois College of Medicine, Chicago 60607, USA.

Insights

The breast tumor kinase (BRK) is identified as an ortholog of mouse Sik. BRK is expressed in differentiated gastrointestinal cells and may be linked to epithelial tumor development.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • The breast tumor kinase (BRK) is a non-receptor tyrosine kinase.
  • BRK is structurally related to the mouse epithelial-specific tyrosine kinase (Sik).

Purpose of the Study:

  • To isolate and characterize BRK.
  • To investigate the expression pattern of BRK in the gastrointestinal tract and colon tumors.
  • To explore the potential role of BRK in epithelial differentiation and tumorigenesis.

Main Methods:

  • cDNA library screening
  • Southern blot hybridization
  • Gene mapping
  • RNase protection assays
  • In situ hybridization
  • Immunohistochemistry

Main Results:

  • BRK was identified as an ortholog of Sik, sharing 80% amino acid identity.
  • The BRK gene is located on human chromosome 20q13.3.
  • BRK is expressed in differentiated epithelial cells of the normal gastrointestinal tract.
  • BRK expression increases during Caco-2 colon adenocarcinoma cell differentiation.
  • Modest increases in BRK expression were observed in primary colon tumors.

Conclusions:

  • BRK plays a role in signal transduction in the normal gastrointestinal tract.
  • BRK overexpression may contribute to the development of epithelial tumors.

Related Concept Videos